New postoperative implant is effective

Wednesday, November 26 2014 | 00 h 00 min | Vision Science

The first ever tear duct implant developed to treat inflammation and pain following cataract surgery could be a good alternative to eye drops.

The device automatically delivers the correct level of postoperative medication in patients. After 30 days, it liquefies and is evacuated through the tear ducts, without the need for outside intervention.

Tested in four American ophthalmology practices, the device delivered dexamethasone into the eyes of 30 patients over 30 days, while 30 other patients received a placebo. On day one, the placebo group reported pain three times higher than the medicated group. After 14 days, the pain was 11 times higher than it was for the others.

For further information: http://www.newswise.com/articles/tear-duct-implant-effective-at-reducing-pain-and-inflammation-in-cataract-surgery-patients

Served with Style

Created with French chef Mathieu Pérou, Silure de Loire pairs a round acetate silhouette with tortoise tones, subtle green accents and resin details inspired by fish scales.

Learn More

Transitions Students of Vision 2026 - EN

Students of Vision Challenges Future Eye Care Professionals to Reimagine Light Management

The Students of Vision Scholarship Program, presented by Transitions Optical and the Opticians Association of Canada, challenges future eye care professionals to develop a creative initiative that helps young adults better understand the impact of light on visual comfort, performance and everyday life. Top submissions will receive scholarships and smart eyewear equipped with Transitions lenses.